Title
Effect of Nebulized Lidocaine on Postoperative Sore Throat
Effect of Preoperative Nebulized Lidocaine on Postoperative Sore Throat After Endotracheal Intubation
Phase
N/ALead Sponsor
Antalya Training and Govermental HospitalStudy Type
InterventionalStatus
TerminatedIndication/Condition
Sore ThroatIntervention/Treatment
Lidocaine ...Study Participants
110The purpose of this study is to test the hypothesis that use of preoperative nebulized lidocaine is reduced the incidence of postoperative sore throat after endotracheal intubation.
Adult patients undergoing video-assisted thoracic surgery (VATS) requiring double lumen tube (DLT) endotracheal intubation for one-lung ventilation (OLV) were enrolled in the study. Patients were randomized by means of computer-generated order randomization into two groups: Group C (those who received a saline solution as placebo delivered by nebulization) and Group L (those who received lidocaine delivered by nebulization).
At 1, 6 and 24 h after tracheal extubation, an observer blinded to treatments evaluated the patients in terms of sore throat and hoarseness. In addition, Patients' satisfaction, intraoperative and postoperative opioid and analgesics consumption and complaints such as dysphagia, nausea and vomiting were recorded. Hemodynamic variables such as blood pressure and heart rate were also recorded.
Effect of saline on postoperative sore throat
Effect of nebulized lidocaine on postoperative sore throat
In Control Group, 4 mL of saline solution was administered using a face mask and a compressed gas-powered jet nebulizer for 15 min
In Lidocaine Group 4 mL of 4% lidocaine was administered using a face mask and a compressed gas-powered jet nebulizer for 15 min
Inclusion Criteria: patients undergoing video-assisted thoracic surgery requiring double lumen tube endotracheal intubation for one-lung ventilation American Society of Anesthesiologists class 1,2 and 3 Ability to consent Exclusion Criteria: patients <18 years old body mass index (BMI) <20 or >35 kg/m2 Mallampati grade 3 or 4 mouth opening < 3 cm preexisting hoarseness or sore throat coagulopathy patient with upper respiratory tract infection